Skip to main content

Table 4 Analysis of fibrosis on OS and DSS stratified by TNM stage and therapy

From: Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database?

TNM Stage Therapy Overall Survival Disease-specific Survival
HR (95%CI) P Value HR (95%CI) P Value
I + II No 1.03(0.91–1.17) 0.612 0.98(0.85–1.12) 0.756
Yes 1.11(0.98–1.27) 0.098 1.08(0.93–1.26) 0.302
III + IV No 1.09(0.99–1.20) 0.085 1.07(0.97–1.19) 0.178
Yes 1.08(0.85–1.38) 0.541 1.01(0.78–1.31) 0.956